Brief: Theravet Announces 300% Increase In Participating Centers In Its Osteosarcoma Program
June 15 (Reuters) - Theravet SA ALVET.PA :
* THERAVET ANNOUNCES 300% INCREASE IN PARTICIPATING CENTERS
IN THE
OSTEOSARCOMA PROGRAM SINCE ITS INITIATION 6 MONTHS AGO
* FAST-GROWING INTEREST IN OSTEOSARCOMA PROGRAM SINCE
OFFICIAL
LAUNCH END- MARCH 2023 WITH A 33% INCREASE IN PARTICIPATING
CENTERS
Source text for Eikon: ID:nBw8WlVLGa
Further company coverage: ALVET.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))
Recent news on Theravet SA
See all newsBrief: Theravet Announces Setting Up Of An Equity-Linked Financing Facility
Brief: TheraVet Provides Update On 2023 Half-Year Development And Portfolio Strategy
Brief: Theravet Announces 300% Increase In Participating Centers In Its Osteosarcoma Program
Brief: Theravet End-Dec Cash Position Of EUR 3.19 Mln
Brief: Theravet Signs New Distribution Agreement For Its Biocera-Vet With Elvetis